Sign in
PXMD Stock Price, Chart, Stats & News
PaxMedica, Inc. Common Stock
Save
PaxMedica, Inc. Common Stock (PXMD) does not currently pay a dividend.
63,132
Market cap
–
Current P/E
–
Forward P/E
PXMD chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
PaxMedica, Inc. is a biopharmaceutical company currently in the clinical development phase, dedicated to advancing anti-purinergic drug therapies (APTs). These innovative treatments are specifically designed to address complex neurological disorders presenting with stubborn and persistent symptoms. The company's primary investigative drug is PAX-101, an intravenous (IV) form of suramin, which is being explored for a variety of conditions.
Similar securities
Based on sector and market capitalization
Report issue